Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
Clinical trial NCT04663347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04663347
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2027-09-30
- Enrollment
- 543
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.